BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...

August 12, 2024 | News

Twist Bioscience Expands DNA Synthesis Portfolio with Launch of Longer Gene Fragments up to 5.0kb

-Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform,...

August 09, 2024 | News

Sanyou Bio and JiAnTeBo Forge Strategic Partnership to Innovate Metabolic Disease Therapies

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...

August 08, 2024 | News

Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...

August 07, 2024 | News

Oxford Nanopore Partners with Singapore's NPM to Map Genomic Diversity of Major Ethnic Groups

Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precis...

August 05, 2024 | News

WuXi Biologics Secures EMA GMP Certification for Five Facilities in China

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that four manufacturing facilities ...

August 02, 2024 | News

Innovent Biologics and Sanegene Bio USA Dose First Participant in Phase 1 Trial of Promising siRNA Hypertension Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

August 02, 2024 | News

Sirnaomics Forms Joint Venture with Gore Range Capital to Propel RNAi Therapeutics into Aesthetic Medicine

Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical co...

August 01, 2024 | News

$2 Million Grant Fuels Queensland Drug Discovery Alliance to Propel Therapeutic Innovations

A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic dis...

July 31, 2024 | News

Porton Advanced and Geneseed Biotech Forge Strategic Partnership to Accelerate circRNA Therapies

Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Bio...

July 31, 2024 | News

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

July 30, 2024 | News

Ractigen Therapeutics' RAG-18 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, announced that the U.S. Food and Drug Administration (FDA) has ...

July 26, 2024 | News

Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...

July 24, 2024 | News

Waters Launches High-Throughput RS-DSC for Biologics Stability Testing

Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competito...

July 24, 2024 | News

Stay Connected